{"nct_id":"NCT06745323","title":"A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-02-26","start_date_type":"ACTUAL","primary_completion_date":"2029-02-13","primary_completion_date_type":"ESTIMATED","completion_date":"2029-02-13","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AMGN"]}